Emcure Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 1,502.22 | 1,556.61 | 1,283.36 |
| Operating Expense | 1,096.05 | 1,146.95 | 1,036.01 |
| Net Profit | 233.70 | 258.85 | 117.62 |
| Net Profit Margin | 15.56% | 16.63% | 9.17% |
| Earning Per Share | 12.33 | 13.65 | 6.21 |
| EBIDTA | 412.47 | 419.03 | 253.05 |
| Effective Tax Rate | 19.42% | 15.84% | 18.59% |
Particulars
Mar 2026
Revenue1,502.22
Operating Expense1,096.05
Net Profit233.70
Net Profit Margin15.56
Earning Per Share12.33
EBIDTA412.47
Effective Tax Rate19.42
